Search research articles
Contact Us
Filters
Showing results (241-250 of 253) with videos related to
Page
of 26
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease
Kristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Nature Medicine
|
July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?
Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Scientific Reports
|
May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPD
Katarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
JAMA
|
August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
William McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society
|
September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
Daniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study
Jeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary disease
Lisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
Genome Medicine
|
April 22, 2021
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
Silva Kasela, Victor E Ortega, Molly Martorella, et al.
Circulation. Heart Failure
|
November 5, 2025
SPIROMICS HF: Rationale, Design, and Reproducibility of Measures
R Graham Barr, Joao A C Lima, Martin R Prince, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
Subramanyam J Tantry, Shankar D Markad, Vikas Shinde, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 253) with videos related to
Sort By:
Page
of 26
American Journal of Respiratory and Critical Care Medicine
|
January 23, 2024
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease
Kristopher Opron, Lesa A Begley, John R Erb-Downward, et al.
Nature Medicine
|
July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?
Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Scientific Reports
|
May 22, 2023
A blood and bronchoalveolar lavage protein signature of rapid FEV<sub>1</sub> decline in smoking-associated COPD
Katarina M DiLillo, Katy C Norman, Christine M Freeman, et al.
JAMA
|
August 1, 2023
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
William McKleroy, Tracie Shing, Wayne H Anderson, et al.
Annals of the American Thoracic Society
|
September 8, 2025
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
Daniel T Hoesterey, Hong Dang, Daniela Markovic, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
August 19, 2024
Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study
Jeffrey L Curtis, Lori A Bateman, Susan Murray, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 16, 2024
Dynamic and prognostic proteomic associations with FEV<sub>1</sub> decline in chronic obstructive pulmonary disease
Lisa Ruvuna, Kahkeshan Hijazi, Daniel E Guzman, et al.
Genome Medicine
|
April 22, 2021
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
Silva Kasela, Victor E Ortega, Molly Martorella, et al.
Circulation. Heart Failure
|
November 5, 2025
SPIROMICS HF: Rationale, Design, and Reproducibility of Measures
R Graham Barr, Joao A C Lima, Martin R Prince, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
Subramanyam J Tantry, Shankar D Markad, Vikas Shinde, et al.
Page
of 26